The Wall Street Journal reports that the ex-HealthSouth CEO Richard Scrushy appears to have benefited from a series of rather suspiciously timed stock-option grants during his tenure with the company. Scrushy is the latest CEO to endure the heat of a WSJ backdating investigation, joining UnitedHealth's Dr. Bill McGuire and Renal Care's Sam Brooks. The newspaper notes that Scrushy, who won an acquittal in his federal fraud trial last year, did not exercise any of the options in question, which occurred between 1995 and 2002. He did, however, exercise "a large number" in earlier years.
- read this Wall Street Journal article (sub. req.)